Skip to content

PolitiKit

Lobbying by Diabetes Canada: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Client of a consultant lobbyist

Diabetes Canada

Meetings this Parliament
5
With MPs
0
Since Nov 2021
5
Active registrations
1

Most recent reported meeting: Aug 11, 2026.

Registrations in effect

Consultant In effect since Feb 25, 2026 Receives government funding

Consultant David Campbell of GT & Company Executive Advisors

Consultant lobbyists

  • David Campbell
  • David Campbell

Institutions they may lobby: Canada Revenue Agency (CRA), Canadian Heritage (PCH), Employment and Social Development Canada (ESDC), Finance Canada (FIN), Health Canada (HC), House of Commons, Indigenous Services Canada (ISC), Innovation, Science and Economic Development Canada (ISED), Prime Minister's Office (PMO), Privy Council Office (PCO), Public Health Agency of Canada (PHAC), Public Services and Procurement Canada (PSPC), Senate of Canada, Transport Canada (TC), Treasury Board Of Canada Secretariat (TBS)

What they're lobbying on (4)
  • Increase funds for diabetes in the Federal Budget specifically to increase funds directed to the Framework for Diabetes in Canada its components and a strategy to reflect growth in diabetes prevalence and cost.
  • Increase Federal funding for Diabetes Research - work directed towards increasing funding to federal granting councils, in particular CIHR through the Federal Budget.
  • Engaging government officials on implementation of Bill C-64 - An Act Respecting Pharmacare
  • Aboriginal Diabetes Initiative - work towards making funding for this Initiative permanent. (Previous work directed towards continuation of funding beyond 2010).

Registration 960777-381592-2. Look it up in the official Registry

Reported meetings

Spreadsheet
  • Reported by David Campbell · Consultant

    • Julie Harb · Policy Advisor, Prime Minister's Office (PMO)
    Increase funds for diabetes in the Federal Budget specifically to increase funds directed to the Framework for Diabetes in Canada its components and a strategy to reflect growth in diabetes prevalence and cost. Read more

    Engaging government officials on implementation of Bill C-64 - An Act Respecting Pharmacare

    Official report

  • Reported by David Campbell · Consultant

    • Shannon Ablett · Manager, Stakeholder Relations, Privy Council Office (PCO)
    Increase funds for diabetes in the Federal Budget specifically to increase funds directed to the Framework for Diabetes in Canada its components and a strategy to reflect growth in diabetes prevalence and cost. Read more

    Engaging government officials on implementation of Bill C-64 - An Act Respecting Pharmacare

    Official report

  • Reported by David Campbell · Consultant

    • Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
    Increase funds for diabetes in the Federal Budget specifically to increase funds directed to the Framework for Diabetes in Canada its components and a strategy to reflect growth in diabetes prevalence and cost. Read more

    Engaging government officials on implementation of Bill C-64 - An Act Respecting Pharmacare

    Official report

  • Reported by David Campbell · Consultant

    • Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
    Engaging government officials on implementation of Bill C-64 - An Act Respecting Pharmacare

    Official report

  • Reported by David Campbell · Consultant

    • Mackenzy Metcalfe · Policy Advisor, Finance Canada (FIN)
    • Jessica Fullerton · Policy advisor, Finance Canada (FIN)
    Increase Federal funding for Diabetes Research - work directed towards increasing funding to federal granting councils, in particular CIHR through the Federal Budget. Read more

    Engaging government officials on implementation of Bill C-64 - An Act Respecting Pharmacare

    Increase funds for diabetes in the Federal Budget specifically to increase funds directed to the Framework for Diabetes in Canada its components and a strategy to reflect growth in diabetes prevalence and cost.

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.